Ketogenic Diet Beats Mediterranean Diet for Liver Health in Head-to-Head Trial
A randomized trial compared three diets at equal 10% weight loss — and the ketogenic diet stood out for liver health improvements.
Summary
A randomized clinical trial pitted three popular dietary approaches against each other at equivalent 10% body weight loss: a Mediterranean diet, a very low-fat plant-forward diet, and a very low-carbohydrate ketogenic diet. The study, discussed in a JAMA Medical News article, found that the ketogenic diet produced superior improvements in liver health markers compared to the other two diets. The findings are particularly relevant for the growing epidemic of metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease, which is closely tied to obesity, insulin resistance, and accelerated aging. While the trial results are promising, questions remain about the long-term sustainability and real-world applicability of strict ketogenic eating for the general population.
Detailed Summary
Liver health is increasingly recognized as a central pillar of metabolic aging. Metabolic dysfunction-associated steatotic liver disease affects roughly one-third of adults worldwide and is strongly linked to insulin resistance, cardiovascular disease risk, and premature mortality — placing it squarely in the longevity conversation.
This JAMA Medical News article covers a randomized clinical trial that compared three dietary interventions at a standardized benchmark of 10% body weight loss: a Mediterranean diet, a very low-fat plant-forward diet, and a very low-carbohydrate ketogenic diet. By controlling for the degree of weight loss, the trial was designed to isolate diet composition effects independent of simple caloric deficit.
The ketogenic diet emerged as the standout performer for liver health outcomes, outpacing both the Mediterranean and very low-fat plant-forward diets on key metabolic markers. The article explores what these findings mean in a real-world context — an important distinction, since achieving and sustaining ketosis requires a level of dietary discipline that most patients find challenging outside a controlled trial setting.
The implications for clinicians and health-conscious individuals are meaningful. For patients with hepatic steatosis or insulin resistance, carbohydrate restriction may deliver liver benefits beyond what weight loss alone or other healthy dietary patterns can achieve. This supports a growing body of evidence that macronutrient composition — not just caloric balance — matters for metabolic organ health.
However, significant caveats apply. The article is a news summary of a trial abstract, not a full methods report, so effect sizes, specific biomarkers improved, and follow-up duration remain unclear. Long-term adherence to ketogenic diets in free-living populations is notoriously poor, and whether these liver benefits persist beyond a controlled trial window is unknown. Individualized dietary guidance remains essential.
Key Findings
- Ketogenic diet produced greater liver health improvements than Mediterranean or very low-fat plant-forward diets at equal 10% weight loss.
- Controlling for weight loss magnitude isolates diet composition as the active variable driving liver-specific benefits.
- Carbohydrate restriction may offer metabolic advantages for liver health beyond what caloric deficit alone explains.
- Real-world adherence to ketogenic diets remains a key challenge that may limit translation of trial findings.
Methodology
This is a JAMA Medical News summary of a randomized clinical trial comparing three dietary patterns — Mediterranean, very low-fat plant-forward, and very low-carbohydrate ketogenic — at a standardized 10% body weight loss endpoint. The design controls for weight loss magnitude to isolate macronutrient composition effects. Full trial methodology, sample size, duration, and specific endpoints are not available from the abstract alone.
Study Limitations
This summary is based on a JAMA Medical News article covering the trial, not the full primary research paper, so specific effect sizes, biomarkers, participant characteristics, and follow-up duration are unavailable. Long-term adherence to ketogenic diets in real-world settings is typically poor, limiting generalizability. The abstract does not clarify whether liver improvements were assessed via biopsy, imaging, or blood-based biomarkers, which significantly affects the strength of conclusions.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: